Literature DB >> 24526816

Immunohistochemical Characterization of a Renal Nephroblastoma in a Trp53-mutant and Prolyl Isomerase 1-deficient Mouse.

Vittoria Castiglioni1, Marcella De Maglie2, Roberta Queliti3, Alessandra Rustighi4, Giannino Del Sal4, Enrico Radaelli1.   

Abstract

A nephroblastoma is a tumor arising from metanephric blastema occurring in childhood. Among laboratory rodents, nephroblastoma has been frequently reported in rats, but it remains exceedingly rare in mice. The present work describes a nephroblastoma in a young mouse homozygous for the specific Trp53 R172H point mutation coupled with targeted deletion of the Pin1 gene. The affected kidney was effaced by a biphasic tumor with an epithelial component arranged in tubules surrounded by nests of blastemal cells. Immunohistochemically, the neoplasm was diffusely positive for Wilms' tumor antigen. The epithelial component expressed markers of renal tubular differentiation including wide-spectrum cytokeratin, E-cadherin and folate-binding protein. Furthermore, the neoplasm exhibited a high proliferative index and diffuse nucleocytoplasmic β-catenin expression. Based on histological and immunohistochemical features, a diagnosis of nephroblastoma potentially associated with Trp53 loss and oncogenic β-catenin activation has been proposed.

Entities:  

Keywords:  immunohistochemistry; kidney; mouse; nephroblastoma; pathogenesis

Year:  2013        PMID: 24526816      PMCID: PMC3921926          DOI: 10.1293/tox.2013-0021

Source DB:  PubMed          Journal:  J Toxicol Pathol        ISSN: 0914-9198            Impact factor:   1.628


A nephroblastoma, also known as a “embryonal nephroma” and/or “Wilms’ tumor”, is an embryonal renal tumor originating from metanephric blastema, which is usually described as composed of a mixture of three cell populations: epithelial, mesenchymal and blastemal cells[1]. A nephroblastoma generally arises at one pole of the kidney, and it is considered a malignant neoplasm with metastatic potential[1]. Wilms’ tumor is the most common primary renal tumor of childhood, with a peak incidence between 2 and 3 years of age[2]. The pathogenesis of nephroblastoma has been extensively investigated in human medicine, and genetic alterations have been associated with this malignancy. Mutations of three tumor-suppressor genes (Wilms’ tumor 1, WT1; Wilms’ tumor gene on the X chromosome, WTX; and TP53) and one oncogene (CTNNB1) are reported to occur either singly or in combination[3]. Considering nonhuman species, nephroblastoma is the most common primary renal tumor of pigs[4] and chickens[5]. Nephroblastomas occur far less often in calves[6] and dogs[7] and are occasionally reported in sheep[8], horses[9], cats[10] and fishes[11]. As in humans, nephroblastomas in these animal species are mainly described in young subjects, with only a minority of cases occurring in adults. With reference to laboratory animals, nephroblastomas are commonly described in rats, both as spontaneous[12] and experimentally-induced[13],[14] lesions, and are extremely rare in nonhuman primates[15],[16] and mice[17],[18],[19], with only few cases reported so far. The aim of this study was to describe the pathological and immunohistochemical features of a renal nephroblastoma spontaneously occurring in a genetically engineered young mouse and provide some insights into tumor pathogenesis. The animal considered in this study was a 15-week-old male mouse belonging to a genetically engineered line characterized by Trp53 R172H point mutation on both the alleles coupled with targeted deletion of the Pin1 gene[20]. Mice from this cohort were maintained on a C57BL/6 background. The mouse was sacrificed because of generalized deterioration of clinical conditions and marked abdominal enlargement. A complete necropsy was performed, and samples of representative organs were obtained for histological examination. Samples were trimmed, fixed in 10% buffered formalin, paraffin-embedded, sectioned at four µm and stained with hematoxylin and eosin for histopathological examination. Immunohistochemical analysis was performed in order to confirm the diagnostic hypothesis and to get some insights into the possible pathogenesis of the lesion. Details concerning the panel of immunohistochemical stains applied are listed in Table 1. Negative immunohistochemical controls were prepared by replacing the primary antibody with an irrelevant one, and known positive control sections were included in each immunolabeling assay.
Table 1.

Details Concerning Primary Antibodies and Procedures Used for the Immunohistochemical Examination of the Renal Nephroblastoma Reported in This Study

Procedures involving animals and their care conformed to institutional guidelines in compliance with national (D.L.vo 116/92 and following additions) and international (EEC Council Directive 86/609, OJ L 358, 1, 12-12-1987; NIH Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 1996) laws and policies. At necropsy, ascites was detected, and the left kidney was markedly enlarged by a multinodular, tan and hemorrhagic mass that was up to 1.5 × 3 cm in diameter. Histologically, the renal parenchyma was completely effaced by a densely cellular, partially encapsulated, lobulated mass composed of a mixture of 2 main cell populations and supported by a minimal amount of stroma. The first population consisted of neoplastic epithelial cells arranged in single-layered infolded tubules, which were occasionally filled by necrotic debris (Fig. 1A). Cells were 12–15 µm in diameter and cuboidal to columnar, with distinct cell borders, an intermediate nuclear to cytoplasmic ratio and a moderate amount of pale eosinophilic homogeneous cytoplasm. Nuclei were oval, 10 µm in diameter and central to paracentral with coarsely clumped chromatin and occasionally had an evident nucleolus. Anisocytosis and anisokaryosis were mild; mitoses were rare. The second population of cells (neoplastic blastemal cells) was arranged in closely packed nests centered around the aforementioned tubules (Fig. 1A). Cells were polygonal and up to 20 µm in diameter, with variably distinct cell borders, a high nuclear to cytoplasmic ratio and a scant amount of pale eosinophilic homogeneous cytoplasm. Nuclei were central, 15 µm in diameter and oval with densely clumped chromatin and no evident nucleoli. Anisocytosis and anisokaryosis were moderate to marked, there were 3–6 mitoses per high-power field, often with a bizarre morphology and there were large numbers of scattered apoptotic cells. Closely intermingled with these two atypical cell populations were lesser numbers of atypical spindle cells (neoplastic mesenchymal cells) with indistinct cell borders, an intermediate nuclear to cytoplasmic ratio and a moderate amount of pale eosinophilic homogeneous cytoplasm. Nuclei were central, oval, plump and approximately 15–20 µm in diameter, with marginated chromatin and 1–2 nucleoli. Anisocytosis and anisokaryosis were moderate, and mitoses were rare. Centrally the tumor was effaced by wide coalescing areas of coagulative necrosis and hemorrhages. The perirenal adipose tissue was expanded by moderate numbers of lymphocytes, plasma cells and macrophages, occasionally with their cytoplasm filled by erythrocytes (erythrophagocytosis). Morphologically, the tumor was consistent with a diagnosis of renal nephroblastoma.
Fig. 1.

Kidney; biphasic nephroblastoma in a Trp53-mutant and prolyl isomerase 1-deficient mouse. (A) The tumor is composed of neoplastic epithelial cells arranged in single-layered tubules surrounded by neoplastic blastemal cells arranged in nests. Hematoxylin and eosin, 200×. (B) Both epithelial and blastemal cell populations are characterized by marked and diffuse nuclear immunoreactivity for Wilms’ tumor antigen 1. Wilms’ tumor antigen 1 immunohistochemistry (IHC), 200×. (C) Scant cytoplasmic immunoreactivity for vimentin is observed in the stromal compartment separating neoplastic cell populations. Vimentin IHC, 100×. (D) Neoplastic epithelial cells lining tubules diffusely express cytokeratin. Wide spectrum cytokeratin IHC, 100×. (E) Scattered tubules display FBP immunoreactivity, which is mainly concentrated along the luminal surface of neoplastic epithelial cells. FBP IHC, 200×. (F) Few scattered neoplastic mesenchymal cells are diffusely positive for smooth muscle actin (SMA). SMA IHC, 200×. (G) A large number of Ki-67-positive neoplastic cells are evident in the blastemal compartment, whereas only scattered Ki-67-positive neoplastic epithelial cells line the tubular structures. Ki-67 IHC, 200×. (H) Both epithelial and blastemal cell populations are characterized by marked and diffuse nuclear and cytoplasmic immunoreactivity for β-catenin. β-catenin IHC, 200×.

Kidney; biphasic nephroblastoma in a Trp53-mutant and prolyl isomerase 1-deficient mouse. (A) The tumor is composed of neoplastic epithelial cells arranged in single-layered tubules surrounded by neoplastic blastemal cells arranged in nests. Hematoxylin and eosin, 200×. (B) Both epithelial and blastemal cell populations are characterized by marked and diffuse nuclear immunoreactivity for Wilms’ tumor antigen 1. Wilms’ tumor antigen 1 immunohistochemistry (IHC), 200×. (C) Scant cytoplasmic immunoreactivity for vimentin is observed in the stromal compartment separating neoplastic cell populations. Vimentin IHC, 100×. (D) Neoplastic epithelial cells lining tubules diffusely express cytokeratin. Wide spectrum cytokeratin IHC, 100×. (E) Scattered tubules display FBP immunoreactivity, which is mainly concentrated along the luminal surface of neoplastic epithelial cells. FBP IHC, 200×. (F) Few scattered neoplastic mesenchymal cells are diffusely positive for smooth muscle actin (SMA). SMA IHC, 200×. (G) A large number of Ki-67-positive neoplastic cells are evident in the blastemal compartment, whereas only scattered Ki-67-positive neoplastic epithelial cells line the tubular structures. Ki-67 IHC, 200×. (H) Both epithelial and blastemal cell populations are characterized by marked and diffuse nuclear and cytoplasmic immunoreactivity for β-catenin. β-catenin IHC, 200×. The immunohistochemical profile of the different neoplastic cell populations is summarized in Table 2. Briefly, neoplastic cells belonging to both the epithelial and blastemal components were diffusely positive for Wilms’ tumor antigen 1 and negative for vimentin (Figs. 1B and 1C). The epithelial population arranged in tubules was diffusely positive for wide-spectrum cytokeratin (WSCK) (Fig. 1D), E-cadherin and to a lesser degree for folate-binding Protein (FBP) (Fig. 1E). Smooth muscle actin (SMA) immunohistochemistry highlighted the presence of few scattered intratumoral clusters of atypical spindle cells (Fig. 1F), which were also variably positive for Wilms’ tumor antigen 1. Furthermore, there was diffuse nuclear positivity for Ki-67 within the blastemal cellular population, whereas lesser numbers of positive nuclei were detected within the epithelial cellular population (Fig. 1G). A strong and diffuse nuclear and cytoplasmic positivity for β-catenin could be appreciated within epithelial and blastemal components (Fig. 1H).
Table 2.

Summary of the Immunohistochemical Phenotype Displayed by Epithelial, Blastemal and Mesenchymal Components in Examined Renal Murine Neoplasm

Neither concomitant occurrence of other malignancies nor evidence of metastatic spreading were observed. Of interest, the relatively young age of the affected animal indicates that in mice, nephroblastoma may develop congenitally or as a neonatal lesion, as in other species. The nephroblastoma examined here was mainly composed of two cell populations (namely, epithelial and blastemal cells) with an inconspicuous mesenchymal component. In this context, the tumor was further subclassified as a “biphasic nephroblastoma.” Notably, the neoplastic epithelial component detected in the examined case was composed of cells arranged in tubules with no evidence of primitive glomeruli formation. Though the formation of tufts of atypical epithelial cells projecting into lumina (primitive glomeruli) is a feature commonly associated with these neoplasms, the presence of these structures is not essential for a diagnosis of nephroblastoma. The evidence of a highly basophilic blastema combined with structures differentiating into nephric elements (tubules in this case) are instead mandatory requirements to classify a lesion in the aforementioned category[21]. Furthermore, a classification into different nephroblastoma subtypes based on their histological characteristics and on their relative contents of epithelial and mesenchymal elements has already been performed in swine with the nephroblastic, epithelial, mesenchymal and miscellaneous subtypes described[4]. No metastatic spreading of the disease was observed in this case. Although metastatic dissemination to multiple organs has been described in renal nephroblastomas affecting rats[12], no data regarding metastatic dissemination of murine nephroblastomas have been reported so far. The diffuse positivity observed for Wilms’ tumor antigen 1 confirmed the diagnostic hypothesis of renal nephroblastoma, and this marker was combined with a broader immunohistochemical panel with the aim of better characterizing the renal neoplasm. Tubular positivity for WSCK, E-cadherin and FBP could be interpreted as an attempt of the tumor to differentiate into tubules, considering that FBP is specifically expressed by renal proximal tubules[22] and E-cadherin has a robust expression in the ureteric bud-derived components of the kidney[23]. The paucity of SMA-positive atypical spindle cells supported the notion of a “biphasic” nephroblastoma with minimal mesenchymal differentiation towards smooth muscle tissue. Further immunohistochemical markers were performed in order to better clarify the molecular scenario in which the malignancy arose and to speculate regarding tumor pathobiology. With respect to tumor proliferative index, the three histological components of nephroblastomas (blastemal, epithelial and stromal) are known to have different proliferative potentials, with the highest proliferative index reported to occur in the epithelium[24],[25],[26],[27]. The rationale behind this finding has not been fully elucidated so far, since the epithelial component is universally considered to be more differentiated than the other ones[26],[27]. In contrast, in the case reported here, the greatest number of Ki-67 positive nuclei was observed in the blastemal population, a finding that mirrors the assumption that the blastema is less mature and less differentiated than the other components[26],[27]. Furthermore, the Ki-67 proliferation index in blastemal cells is reported to be an indicator of metastatic potential[28], but no evidence of metastatic spreading was observed in the examined case, despite the exceedingly high numbers of blastemal Ki-67-positive nuclei observed. Mutations occurring in human nephroblastomas involve three tumor-suppressor genes (Wilms’ tumor 1, WT1; Wilms’ tumor gene on the X chromosome; WTX; and TP53) and one oncogene (CTNNB1). In the present case, the diffuse expression of β-catenin observed in both the nucleus and the cytoplasm of neoplastic cells is highly suggestive of an activation of the Wnt oncogenic pathway. β-catenin is encoded by the CTNNB1 gene and is known to undergo somatic stabilizing mutations in human nephroblastomas[3],[23], and it has already been described to be overexpressed in rat nephroblastomas[29]. In the examined case, Trp53 function was also compromised by the specific R172H point mutation. Taken together, these two latter aspects suggest that in this mouse, the combined effect of Trp53 loss and oncogenic β-catenin activation may have played a primary role in nephroblastoma development. It would be extremely intriguing to further investigate the status of WTX and WT1, known to be altered in human nephroblastoma, in order to clarify tumor pathogenesis in mice and compare it with the human counterpart. In conclusion, to the authors’ knowledge, this is the first report providing a detailed immunohistochemical description of nephroblastoma as an exceedingly rare spontaneous murine renal tumor potentially associated with Trp53 loss and oncogenic β-catenin activation.
  27 in total

1.  The histologic, ultrastructural, and immunohistochemical features of a blastema-predominant canine nephroblastoma.

Authors:  R M Simpson; J M Gliatto; H W Casey; W G Henk
Journal:  Vet Pathol       Date:  1992-05       Impact factor: 2.221

2.  ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development.

Authors:  Kate C Shen; Henry Heng; Yaolin Wang; Shu Lu; Guo Liu; Chu-Xia Deng; S C Brooks; Y Alan Wang
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  Spontaneous nephroblastoma in a strain CE/J mouse. A case report.

Authors:  A G Liebelt; B Sass; H J Sobel; R M Werner
Journal:  Toxicol Pathol       Date:  1989       Impact factor: 1.902

4.  A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.

Authors:  Javier E Girardini; Marco Napoli; Silvano Piazza; Alessandra Rustighi; Carolina Marotta; Enrico Radaelli; Valeria Capaci; Lee Jordan; Phil Quinlan; Alastair Thompson; Miguel Mano; Antonio Rosato; Tim Crook; Eugenio Scanziani; Anthony R Means; Guillermina Lozano; Claudio Schneider; Giannino Del Sal
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

5.  Nephroblastoma with transcoelomic metastasis in a Japanese black bull.

Authors:  Yu Yamamoto; Manabu Yamada; Kikuyasu Nakamura; Yuji Takahashi; Toru Miyamoto
Journal:  J Vet Med Sci       Date:  2006-08       Impact factor: 1.267

6.  Expression and prognostic value of the Ki-67 in Wilms' tumor: experience with 48 cases.

Authors:  Ivo Jurić; Zenon Pogorelić; Ivana Kuzmić-Prusac; Mihovil Biocić; Gordana Jakovljević; Jasminka Stepan; Bozidar Zupancić; Srdana Culić; Bozo Kruslin
Journal:  Pediatr Surg Int       Date:  2010-03-20       Impact factor: 1.827

Review 7.  Advances and changes in the treatment of children with nephroblastoma.

Authors:  Wojciech Pietras
Journal:  Adv Clin Exp Med       Date:  2012 Nov-Dec       Impact factor: 1.727

8.  Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas.

Authors:  David Ehrlich; Elisabeth Bruder; Martin A Thome; Carsten N Gutt; Magnus von Knebel Doeberitz; Felix Niggli; Alan O Perantoni; Robert Koesters
Journal:  Pediatr Dev Pathol       Date:  2010 Jan-Feb

9.  Nephroblastomas in the Japanese eel, Anguilla japonica Temminck and Schlegel.

Authors:  P Masahito; T Ishikawa; N Okamoto; H Sugano
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

10.  High cyclin E staining index in blastemal, stromal or epithelial cells is correlated with tumor aggressiveness in patients with nephroblastoma.

Authors:  Dominique Berrebi; Julie Leclerc; Gudrun Schleiermacher; Isabelle Zaccaria; Liliane Boccon-Gibod; Monique Fabre; Francis Jaubert; Alaa El Ghoneimi; Cécile Jeanpierre; Michel Peuchmaur
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  1 in total

1.  Spontaneous pulmonary co-metastasis of hepatoblastoma arising within a hepatocellular carcinoma in an aged C57BL/6J mouse.

Authors:  Vittoria Castiglioni; Enrico Radaelli
Journal:  J Toxicol Pathol       Date:  2018-06-23       Impact factor: 1.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.